Laboratorios Farmaceuticos Rovi (LABFF) News Today C$65.86 0.00 (0.00%) (As of 12/24/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartShort Interest All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period ROVI Corrects English Communication ErrorNovember 8, 2024 | msn.comROVI Retains Control of CDMO Business for GrowthOctober 25, 2024 | msn.comSpanish drugmaker Rovi to keep third-party manufacturing businessOctober 24, 2024 | reuters.comKepler Capital Sticks to Its Buy Rating for Laboratorios Farmaceuticos Rovi (0ILL)September 12, 2024 | markets.businessinsider.comLaboratorios Farmaceuticos Rovi (0ILL) Receives a Buy from Kepler CapitalAugust 28, 2024 | markets.businessinsider.comBNP PARIBAS EXANE Downgrades Laboratorios Farmaceuticos Rovi (LABFF)August 12, 2024 | msn.comLaboratorios Farmaceuticos Rovi, S.A. reports 1H resultsAugust 2, 2024 | msn.comRovi (ROVI)July 20, 2024 | es.investing.comLaboratorios Farmaceuticos Rovi, S.A. reports FY resultsFebruary 27, 2024 | msn.comLaboratorios Farmaceuticos Rovi, S.A. (41L.F)February 10, 2024 | finance.yahoo.comLaboratorios Farmaceuticos Rovi S.A. (ROVI)December 14, 2023 | es.investing.comLaboratorios Farmaceuticos Rovi SA ROVINovember 11, 2023 | morningstar.comLaboratorios Richmond SACIF (RICH)October 13, 2023 | investing.comCAIXABANK BPI Maintains Laboratorios Farmaceuticos Rovi (XMAD:ROVI) Buy RecommendationJune 8, 2023 | msn.comALANTRA EQUITIES Upgrades Laboratorios Farmaceuticos Rovi (XMAD:ROVI)June 8, 2023 | msn.comLaborat.Rovi (ROVI) Earnings Dates & ReportsMay 9, 2023 | investing.comLaboratorios Farmaceuticos Rovi S.A.April 25, 2023 | wsj.comAt Rovi, Activist Investor's Years of Protests Against Executive Pay May Give Leverage on BoardApril 11, 2023 | thestreet.comLogista (LOG)April 6, 2023 | es.investing.comLaboratorios Farmaceuticos Rovi, S.A. (ROVI.MC)January 13, 2023 | finance.yahoo.comLaboratorios Farmaceuticos ROVI SANovember 22, 2022 | reuters.com Get Laboratorios Farmaceuticos Rovi News Delivered to You Automatically Sign up to receive the latest news and ratings for LABFF and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (Ad)Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it. Click here to watch this demo and decide for yourself. LABFF Media Mentions By Week LABFF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LABFF News Sentiment▼-1.000.62▲Average Medical News Sentiment LABFF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LABFF Articles This Week▼10▲LABFF Articles Average Week Get Laboratorios Farmaceuticos Rovi News Delivered to You Automatically Sign up to receive the latest news and ratings for LABFF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Algernon Pharmaceuticals News Today ALK-Abelló A/S News Today Alpha Tau Medical News Today Apollomics News Today Arno Therapeutics News Today Ascentage Pharma Group International News Today Ascletis Pharma News Today Avacta Group News Today Awakn Life Sciences News Today AXIM Biotechnologies News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:LABFF) was last updated on 12/26/2024 by MarketBeat.com Staff From Our PartnersTSLA *BANG* incoming (bullet in the chamber rn)I just pinpointed 5 dirt-cheap stocks that could soar the second the shot goes off. Thanks to Donald Trump’...StocksToTrade | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredI was wrong. Dead wrong. Something is stirring deep in Silicon Valley. My team and I have been watching the tech markets closely. ...Porter & Company | SponsoredElon Musk could help pay for your retirementElon Musk is the richest man in the world... And he's pouring trillions into a unique investment.Brownstone Research | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Laboratorios Farmaceuticos Rovi, S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Laboratorios Farmaceuticos Rovi With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
